Navigation Links
Mindray DS USA Appoints Michael Thompson Vice President of U.S. Ultrasound Sales
Date:9/4/2009

MAHWAH, N.J., Sept. 4 /PRNewswire-Asia/ -- Mindray DS USA, a Mindray Global Company, announces the recent appointment of Michael Thompson as vice president of ultrasound sales for the U.S. Thompson brings more than 20 years of medical sales, sales force management and business development to the position.

"Mindray has experienced substantial revenue growth in its ultrasound product line throughout the world," said Frank Gregorio, vice president of Sales Operations, Mindray DS USA. "Now we are focusing on growing our ultrasound business in the U.S., which is the largest ultrasound market in the world. With his excellent experience and track record, we are pleased to have Michael lead our efforts in providing affordable, state-of-the-art ultrasound solutions to this strategic market."

With U.S. headquarters in Mahwah, N.J., Mindray was founded in 1991 in Shenzhen, China, with a mission to deliver high-quality, competitively priced medical devices to make healthcare more accessible and affordable around the world. The company's ultrasound platform has especially experienced growth and is recognized for its significant performance to value ratio. Mindray acquired the Datascope Patient Monitoring division in 2008 and merged the North American business together to form Mindray DS USA, a new health care organization which designs, manufactures, and sells, medical imaging, patient monitoring, anesthesia delivery, and in-vitro diagnostic products.

"I am very impressed with the high image quality and value proposition of the Mindray ultrasound technology," said Thompson. "More than ever before, the North American health care systems are searching for cost effective, capital equipment solutions, without sacrificing performance. Mindray is well positioned to meet these market needs. The Mindray ultrasound systems are also very reliable which has resulted in tremendous customer satisfaction. I look forward to expanding the company's presence in the $1.4 billion U.S. market and providing our customers with these well-proven ultrasound platforms."

Prior to joining Mindray, Thompson was the director of business development and corporate accounts at ZONARE Medical Systems, a developer of compact ultrasound systems. At ZONARE, he led a team that was responsible for supporting numerous national accounts including Kaiser Permanente and Health Trust. Thompson also held executive positions at Datascope Corporation, where he built a national organization to support customer sales and service. He holds a Bachelor in Business Administration from the University of Wisconsin.

About Mindray

We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China and through our worldwide distribution network, we are able to supply internationally a broad range of products across three primary business segments, comprised of patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. For more information, please visit http://ir.mindray.com .

About Mindray DS USA

Mindray DS USA manufactures products found throughout the hospital, and is largely focused in the areas of anesthesia, emergency medicine and critical care. Medical facilities that count on our products can be found in over 80 countries across the world. To learn more, please visit http://www.datascopemonitors.us .

    For investor and media inquiries please contact:

    In the U.S.:
     Evan Smith, CFA
     FD
     Tel:   +1-212-850-5606
     Email: evan.smith@fd.com

     John Capodanno
     FD
     Tel:   +1-212-850-5705
     Email: john.capodanno@fd.com

'/>"/>
SOURCE Mindray DS USA; Mindray
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Mindray Medical to Participate in the SIG Third Annual Beijing Management Summit
2. Mindray Medical to Present at the Credit Lyonnais Securities Asia Investors Forum
3. Mindray Medical to Present at the Morgan Stanley Global Healthcare Unplugged Conference
4. Mindray Announces Second Quarter 2009 Financial Results
5. Mindray Medical Provides Mid-Year Update on Product Development and GPO Contracts
6. Mindray to Report Second Quarter 2009 Financial Results on August 10, 2009
7. Mindray to Attend the 2009 American Association for Clinical Chemistry Conference
8. Mindray Announces First Quarter 2009 Financial Results
9. Mindray Files Annual Report on Form 20-F with U.S. Securities and Exchange Commission
10. Mindray to Report First Quarter 2009 Financial Results on May 11, 2009
11. Mindray Medical to Exhibit New Products at 61st China International Medical Equipment Fair
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... 2017 , ... With ProGlass Prism users now have the ability to simulate ... over position, rotation, distortion, edge softness, edge blur, chromatic aberration, individual glass position offset, ... ProGlass Prism users are given the tools and effects to generate a fractal ...
(Date:2/24/2017)... ... , ... The International Association of Eating Disorders Professionals (iaedp) announces the 2017 ... image mannequin art competition. Selected from 15 submissions from around the nation, the top ... 31st annual iaedp Symposium, March 22 – 26 in Las Vegas. , This year, ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... which specializes in thought leadership , media relations, social media, content marketing ... that will be powered through Act-On, an intuitive marketing automation platform. , Rosica ...
(Date:2/23/2017)... ... February 23, 2017 , ... Thinksport, the most award-winning ... Gran Fondo of Marin. For the second year in a row, cyclists will ... , “We are thrilled to provide our safe, non-toxic sunscreen to over 2,000 ...
(Date:2/23/2017)... ... February 23, 2017 , ... The Lymphoma ... innovative lymphoma research and serving the lymphoma community through a comprehensive series of ... Gorce Country Club in Miami Beach to host its Swirl: Miami Wine Tasting ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... Feb. 23, 2017 Non-alcoholic steatohepataitis ... the various drugs being developed for the ... the drugs that are in various phases ... pipeline focuses on novel pharmacologic drugs & ... cell therapies, recombinant proteins and RNA-based therapeutics, ...
(Date:2/24/2017)... , Feb. 24, 2017  Xynomic Pharmaceuticals, Inc., an ... that it has acquired exclusive worldwide rights to ... innovative HDAC inhibitor targeting hematological and solid tumors. ... Phase 1 and 2 clinical trials of Abexinostat ... have already been completed, demonstrating that Abexinostat ...
(Date:2/23/2017)... DUBLIN , Feb 23, 2017 Research ... Disorder Drugs Price Analysis and Strategies - 2016" report to ... ... - 2016, provides drug pricing data and benchmarks in the global ... What are the key drugs marketed ...
Breaking Medicine Technology: